Class information for:
Level 1: BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES//CT P13

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
14993 737 30.8 57%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
350 3       COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY 35656
1655 2             BIOSIMILAR//FCRN//PROTEIN FORMULATION 6878
14993 1                   BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES//CT P13 737

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BIOSIMILAR authKW 5023405 33% 50% 244
2 ANTI ERYTHROPOIETIN ANTIBODIES authKW 913198 3% 96% 23
3 CT P13 authKW 822889 3% 83% 24
4 FOLLOW ON BIOLOGICS authKW 517867 3% 63% 20
5 PURE RED CELL APLASIA authKW 456865 8% 19% 58
6 SIMILAR BIOTHERAPEUTIC PRODUCTS authKW 417757 1% 92% 11
7 SUBSEQUENT ENTRY BIOLOGICS authKW 290014 1% 100% 7
8 EPOETIN ZETA authKW 265153 1% 80% 8
9 PRCA authKW 216768 2% 35% 15
10 REFERENCE PRODUCT authKW 213070 1% 86% 6

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 2366 34% 0% 251
2 Urology & Nephrology 1376 13% 0% 97
3 Rheumatology 951 7% 0% 50
4 Biotechnology & Applied Microbiology 602 13% 0% 98
5 Transplantation 391 5% 0% 38
6 Biochemical Research Methods 241 7% 0% 51
7 Health Care Sciences & Services 232 4% 0% 31
8 Health Policy & Services 225 3% 0% 23
9 Gastroenterology & Hepatology 219 6% 0% 44
10 Medicine, Research & Experimental 187 7% 0% 52

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IMED MED 165722 1% 100% 4
2 SCML 93217 0% 75% 3
3 CLIN PLANNING MED AFFAIRS 82861 0% 100% 2
4 OFF BIOL 1 82861 0% 100% 2
5 SECT NONCORONAROGEN MYOCARDIAL DIS CLIN RHEUMAT 82861 0% 100% 2
6 SERV FARMACEUT 7 82861 0% 100% 2
7 TERNOPIL REG COUNCIL 82861 0% 100% 2
8 TERNOPIL UNIV HOSP 82861 0% 100% 2
9 SANDOZ BIOPHARMACEUT 74567 1% 30% 6
10 INNOVAT STUDIES 58247 2% 9% 16

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BIOLOGICALS 37277 5% 3% 35
2 BIODRUGS 37192 4% 3% 30
3 EJHP PRACTICE 10188 1% 4% 7
4 BIOTECHNOLOGY LAW REPORT 7085 1% 3% 5
5 MABS 6790 1% 1% 11
6 JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY 4010 1% 2% 4
7 NEPHROLOGY DIALYSIS TRANSPLANTATION 3612 4% 0% 33
8 EXPERT OPINION ON BIOLOGICAL THERAPY 3329 2% 1% 13
9 BIOPHARM INTERNATIONAL 2840 1% 1% 6
10 DRUG DISCOVERY TODAY 2832 2% 1% 13

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 BIOSIMILAR 5023405 33% 50% 244 Search BIOSIMILAR Search BIOSIMILAR
2 ANTI ERYTHROPOIETIN ANTIBODIES 913198 3% 96% 23 Search ANTI+ERYTHROPOIETIN+ANTIBODIES Search ANTI+ERYTHROPOIETIN+ANTIBODIES
3 CT P13 822889 3% 83% 24 Search CT+P13 Search CT+P13
4 FOLLOW ON BIOLOGICS 517867 3% 63% 20 Search FOLLOW+ON+BIOLOGICS Search FOLLOW+ON+BIOLOGICS
5 PURE RED CELL APLASIA 456865 8% 19% 58 Search PURE+RED+CELL+APLASIA Search PURE+RED+CELL+APLASIA
6 SIMILAR BIOTHERAPEUTIC PRODUCTS 417757 1% 92% 11 Search SIMILAR+BIOTHERAPEUTIC+PRODUCTS Search SIMILAR+BIOTHERAPEUTIC+PRODUCTS
7 SUBSEQUENT ENTRY BIOLOGICS 290014 1% 100% 7 Search SUBSEQUENT+ENTRY+BIOLOGICS Search SUBSEQUENT+ENTRY+BIOLOGICS
8 EPOETIN ZETA 265153 1% 80% 8 Search EPOETIN+ZETA Search EPOETIN+ZETA
9 PRCA 216768 2% 35% 15 Search PRCA Search PRCA
10 REFERENCE PRODUCT 213070 1% 86% 6 Search REFERENCE+PRODUCT Search REFERENCE+PRODUCT

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DANESE, S , BONOVAS, S , PEYRIN-BIROULET, L , (2017) BIOSIMILARS IN IBD: FROM THEORY TO PRACTICE.NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. VOL. 14. ISSUE 1. P. 22 -31 34 76% 1
2 DORNER, T , STRAND, V , CORNES, P , GONCALVES, J , GULACSI, L , KAY, J , KVIEN, TK , SMOLEN, J , TANAKA, Y , BURMESTER, GR , (2016) THE CHANGING LANDSCAPE OF BIOSIMILARS IN RHEUMATOLOGY.ANNALS OF THE RHEUMATIC DISEASES. VOL. 75. ISSUE 6. P. 974 -982 26 70% 4
3 MACDOUGALL, IC , ROGER, SD , DE FRANCISCO, A , GOLDSMITH, DJA , SCHELLEKENS, H , EBBERS, H , JELKMANN, W , LONDON, G , CASADEVALL, N , HORL, WH , ET AL (2012) ANTIBODY-MEDIATED PURE RED CELL APLASIA IN CHRONIC KIDNEY DISEASE PATIENTS RECEIVING ERYTHROPOIESIS-STIMULATING AGENTS: NEW INSIGHTS.KIDNEY INTERNATIONAL. VOL. 81. ISSUE 8. P. 727 -732 28 82% 24
4 BECK, M , MICHEL, B , RYBARCZYK-VIGOURET, MC , LEVEQUE, D , SORDET, C , SIBILIA, J , VELTEN, M , (2017) KNOWLEDGE, BEHAVIORS AND PRACTICES OF COMMUNITY AND HOSPITAL PHARMACISTS TOWARDS BIOSIMILAR MEDICINES: RESULTS OF A FRENCH WEB-BASED SURVEY.MABS. VOL. 9. ISSUE 2. P. 384 -391 22 100% 0
5 YOO, DH , PRODANOVIC, N , JAWORSKI, J , MIRANDA, P , RAMITERRE, E , LANZON, A , BARANAUSKAITE, A , WILAND, P , ABUD-MENDOZA, C , OPARANOV, B , ET AL (2017) EFFICACY AND SAFETY OF CT-P13 (BIOSIMILAR INFLIXIMAB) IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON BETWEEN SWITCHING FROM REFERENCE INFLIXIMAB TO CT-P13 AND CONTINUING CT-P13 IN THE PLANETRA EXTENSION STUDY.ANNALS OF THE RHEUMATIC DISEASES. VOL. 76. ISSUE 2. P. 355 -363 13 39% 10
6 MYSLER, E , PINEDA, C , HORIUCHI, T , SINGH, E , MAHGOUB, E , COINDREAU, J , JACOBS, I , (2016) CLINICAL AND REGULATORY PERSPECTIVES ON BIOSIMILAR THERAPIES AND INTENDED COPIES OF BIOLOGICS IN RHEUMATOLOGY.RHEUMATOLOGY INTERNATIONAL. VOL. 36. ISSUE 5. P. 613 -625 27 68% 2
7 JACOBS, I , PETERSEL, D , SHANE, LG , NG, CK , KIRCHHOFF, C , FINCH, G , LULA, S , (2016) MONOCLONAL ANTIBODY AND FUSION PROTEIN BIOSIMILARS ACROSS THERAPEUTIC AREAS: A SYSTEMATIC REVIEW OF PUBLISHED EVIDENCE.BIODRUGS. VOL. 30. ISSUE 6. P. 489 -523 29 69% 0
8 RENWICK, MJ , SMOLINA, K , GLADSTONE, EJ , WEYMANN, D , MORGAN, SG , (2016) POSTMARKET POLICY CONSIDERATIONS FOR BIOSIMILAR ONCOLOGY DRUGS.LANCET ONCOLOGY. VOL. 17. ISSUE 1. P. E31 -E38 20 80% 3
9 MANTZARIS, GJ , (2016) ANTI-TNFS: ORIGINATORS AND BIOSIMILARS.DIGESTIVE DISEASES. VOL. 34. ISSUE 1-2. P. 132 -139 23 85% 0
10 WEISE, M , BIELSKY, MC , DE SMET, K , EHMANN, F , EKMAN, N , GIEZEN, TJ , GRAVANIS, I , HEIM, HK , HEINONEN, E , HO, K , ET AL (2012) BIOSIMILARS: WHAT CLINICIANS SHOULD KNOW.BLOOD. VOL. 120. ISSUE 26. P. 5111-5117 16 94% 89

Classes with closest relation at Level 1


Rank Class id link
1 18498 BIOANALYSIS//ANTI DRUG ANTIBODIES//LIGAND BINDING ASSAY
2 8514 PROTEIN FORMULATION//PROTEIN AGGREGATION//SUBVISIBLE PARTICLES
3 32356 DRUG SHORTAGES//JAMES PARKINSON//MEDICINE SHORTAGES
4 7855 PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM
5 24270 INTERFERON ANTIBODIES//CYTOKINE AUTOANTIBODIES//AUTOANTIBODIES TO CYTOKINES
6 28333 FOOD AND DRUG LAW JOURNAL//INTELLECTUAL PROPERTY PROGRAM//ADDITIONAL PATENT
7 1303 ERYTHROPOIETIN//ANEMIA//ERYTHROPOIESIS STIMULATING AGENTS
8 10015 PURE RED CELL APLASIA//LARGE GRANULAR LYMPHOCYTES//LARGE GRANULAR LYMPHOCYTE LEUKEMIA
9 5041 ERYTHROPOIETIN//BLOOD DOPING//ANTIANEMIC AGENTS
10 1645 INFLIXIMAB//CROHNS DISEASE//MUCOSAL HEALING

Go to start page